Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹4 Cr
Revenue (TTM)
₹2 Cr
Net Profit (TTM)
₹0 Cr
ROE
0 %
ROCE
2.5 %
P/E Ratio
38.7
P/B Ratio
-9.4
Industry P/E
--
EV/EBITDA
159.7
Div. Yield
0 %
Debt to Equity
-9.8
Book Value
₹-1.2
EPS
₹0.3
Face value
10
Shares outstanding
3,465,900
CFO
₹-2.55 Cr
EBITDA
₹-0.87 Cr
Net Profit
₹-1.46 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hemo Organic
| -33.6 | -30.3 | -32.3 | 26.4 | 17.1 | -5.5 | -4.9 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Hemo Organic
| 50.3 | 58.1 | -26.7 | 31.8 | -45.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hemo Organic
|
11.4 | 4.0 | 2.4 | 0.1 | -2.4 | -- | 38.7 | -9.4 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 4.3 | 5.2 | 0.5 | -0.1 | -89.9 | -- | -- | 0.4 | |
| 27.0 | 15.4 | 8.0 | 0.6 | 13.8 | 5.5 | 24.4 | 1.2 | |
| 1,547.6 | 29,354.2 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.7 | 5.9 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 189.3 | 246.0 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 49.3 | |
| 24.8 | 42.5 | 49.3 | 0.8 | 1.6 | 4.5 | 55.9 | 2.5 | |
| 32.4 | 31.3 | 67.2 | 2.1 | 3.3 | 4.9 | 15.3 | 0.9 | |
| 114.3 | 73.5 | 65.4 | 2.8 | 6.6 | 12.1 | 26.4 | 3.0 |
No Review & Analysis are available.
Manufacture of ayurvedic' or unani' pharmaceutical preparation
Incorporated
1992
Chairman
--
Managing Director
Vishwambar Kameshwar Singh
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Hemo Organic Ltd is ₹11.40 (BSE) as of 02-Apr-2026 IST. Hemo Organic Ltd has given a return of 17.1% in the last 3 years.
The P/E ratio of Hemo Organic Ltd is 38.74 times as on 02-Apr-2026.
The P/B ratio of Hemo Organic Ltd is -9.35 times as on 02-Apr-2026, a 119 discount to its peers’ median range of 49.27 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.97
|
-20.52
|
|
2024
|
0.00
|
-11.21
|
|
2023
|
0.00
|
-48.06
|
|
2022
|
0.00
|
5,177.65
|
|
2021
|
0.00
|
76.90
|
The 52-week high and low of Hemo Organic Ltd are Rs 22.51 and Rs 8.08 as of 03-Apr-2026.
Hemo Organic Ltd has a market capitalisation of ₹ 4 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Hemo Organic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.